The introduction of nicotinamide as being a nicotine replacement in e-cigarette and smokeless products and solutions signifies a big regulatory problem with the FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is understood to act as a sedative at substantial dosages6. The promises made by Nicotine River, ECBlend, as well as o… Read More